
The current AGL market cap is 1.6B. The company's latest EPS is USD -0.6310 and P/E is -6.18.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 815.5M | 1.6B | 1.48B | 1.46B | 1.52B |
Operating Income | -167.62M | -1.49M | -33.39M | -125.12M | -107.2M |
Net Income | -230.43M | -6.06M | -30.68M | -107.15M | -106.38M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.22B | 1.83B | 2.71B | 4.32B | 6.06B |
Operating Income | -56.67M | -393.95M | -120.43M | -215.64M | -274.03M |
Net Income | -60.05M | -406.49M | -106.55M | -262.6M | -260.15M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.74B | 2.32B | 2.16B | 0 | 0 |
Total Liabilities | 1.08B | 1.63B | 1.49B | 0 | 0 |
Total Equity | 661.02M | 688.49M | 675.87M | 0 | 0 |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 446.36M | 1.59B | 1.7B | 1.74B | 1.73B |
Total Liabilities | 421.59M | 494.66M | 656.86M | 1.08B | 1.26B |
Total Equity | -284.73M | 1.09B | 1.04B | 661.02M | 470.95M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -156.2M | -47.78M | -66.49M | N/A | N/A |
Investing | -44.02M | 51.44M | 69.66M | N/A | N/A |
Financing | -193.13M | 559k | -1.16M | N/A | N/A |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -53.2M | -148.16M | -130.81M | -156.2M | -57.78M |
Investing | 22.07M | -90.51M | -444.39M | -44.02M | 139.89M |
Financing | 24.62M | 1.15B | 28.06M | -193.13M | -2.58M |
Market Cap | 1.6B |
Price to Earnings Ratio | -6.18 |
Price to Sales Ratio | 0.27 |
Price to Cash Ratio | 8.54 |
Price to Book Ratio | 3.41 |
Dividend Yield | - |
Shares Outstanding | 412.3M |
Average Volume (1 week) | 6.18M |
Average Volume (1 Month) | 6.81M |
52 Week Change | -25.48% |
52 Week High | 7.73 |
52 Week Low | 1.50 |
Spread (Intraday) | 0.01 (0.26%) |
Company Name | Agilon Health inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.agilonhealth.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.